Hopkinton, MA, United States of America

Scott C Malcolm



 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 30(Granted Patents)


Location History:

  • Hopkinton, MA (US) (2008 - 2015)
  • Southborough, MA (US) (2011 - 2020)

Company Filing History:


Years Active: 2008-2020

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):

Title: **Scott C. Malcolm: Innovator in Pharmaceutical Chemistry**

Introduction

Scott C. Malcolm is an accomplished inventor based in Hopkinton, MA, known for his significant contributions to pharmaceutical chemistry. With a portfolio of 15 patents, he has developed novel compounds that address critical health issues, particularly in the realm of central nervous system (CNS) and metabolic disorders.

Latest Patents

Among his latest patents, Malcolm has focused on the development of "Substituted cyclopropanes as PDE-10 inhibitors." This invention presents an innovative class of cyclopropane compounds, along with their pharmaceutical compositions, which are designed to treat various CNS and metabolic diseases and disorders. Additionally, he has patented "Cycloalkylamines as monoamine reuptake inhibitors," which describes the synthesis and application of novel cyclohexylamine derivatives. These compounds are aimed at treating CNS disorders such as depression, anxiety, schizophrenia, and sleep disturbances. This particular patent also details methods for inhibiting the reuptake of key monoamines, including dopamine, serotonin, and norepinephrine, thus modulating their levels in the synaptic cleft.

Career Highlights

Malcolm's work has predominantly been associated with esteemed organizations, including Sunovion Pharmaceuticals Inc. and the University of Delaware. His achievements at these institutions have paved the way for advancements in pharmaceutical therapies, helping to bridge the gap between research and tangible medical solutions.

Collaborations

Throughout his career, Scott C. Malcolm has collaborated with notable professionals in the field, including Liming Shao and Fengjiang Wang. These partnerships have further propelled his innovations and have contributed to the successful development of several promising therapeutic compounds.

Conclusion

Scott C. Malcolm exemplifies the spirit of innovation in the pharmaceutical industry. With his impressive patent portfolio and collaborative efforts, he continues to impact the treatment of CNS and metabolic disorders. His work remains crucial in the pursuit of effective medical therapies, contributing significantly to the field of pharmaceutical chemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…